Fierce Biotech

Chutes & Ladders—Tang takes over Aurinia after FDA brouhaha

Published

2 weeks ago

on

Seasoned biotech takeover titan Kevin Tang has struck again. After serving as board chair of Aurinia since 2024, Tang has now ascended to the CEO spot and swapped out the company’s C-suite with a cadre of his close colleagues.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version